Alcon AG reported $297M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
AstraZeneca USD 3.16B 3.95B Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Essilor EUR 2.3B 919M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 268M 395M Mar/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 1.05B 572M Mar/2026
Novartis USD 4.75B 515M Jun/2026
Philips EUR 610M 308M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
Smith & Nephew USD 505M 65M Jun/2026
Sonova Holding CHF 296.8M 156.9M Dec/2025
UCB EUR 1.29B 571M Dec/2025